Tag: FDA
“Right to Try” Can Lead to a Rise in Beneficial Orphan Drugs
Reading Time: 2 minutes Market Research firm Kalorama Information said in a statement that “recently signed legislation to give terminally ill patients the right to use experimental medications could boost the market for orphan […]